Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])
Dr Zoubida TAZI MEZALEK – Cardiologue CHU de Rabat MAROC Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]) https://pubmed.ncbi.nlm.nih.gov/33667442/ PMID : 33667442
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression.
Dr Eve CARIOU – Cardiologue CHU de Toulouse Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression. https://pubmed.ncbi.nlm.nih.gov/33129740/ PMID : 33129740